A CD24-p53 axis contributes to African American prostate cancer disparities.
Wei LiuYue ZhangShi WeiSejong BaeWei-Hsiung YangGary J SmithJames L MohlerElizabeth T H FonthamJeannette T BensenGuru P SonpavdeGuo-Yun ChenRunhua LiuLizhong WangPublished in: The Prostate (2020)
The CD24-p53 axis may contribute to aggressive and metastatic prostate cancers, especially those of AAs. This observation enhances understanding of the pathogenesis of prostate cancer and its associated racial disparities.